Through cutting-edge science and medicine, Biogen finds, develops and delivers innovative treatments worldwide for individuals living with severe neurological and neurodegenerative diseases.

Biogen also produces and commercializes biosimilars of innovative biologics. With roughly 7000 people worldwide, we are truly a worldwide company, headquartered in Cambridge, Massachusetts, which is also home to our study operations.

Our global headquarters are located in Zug, Switzerland and we've got world-class production facilities in North Carolina and Denmark.

We provide therapies worldwide through direct affiliate existence in 30 states and a network of distribution partners in over 50 other countries.